Metraipolis › archive › dc_6df6a07f3ccd
R263K-associated dolutegravir resistance on tenofovir, lamivudine and dolutegravir: Implications for earlier genotyping and regimen optimisation — Europe PMC PMID:41959931
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41959931
- DOI
- 10.4102/sajid.v41i1.790
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T07:40:21.692Z
- SHA-256 of the archived text
9106940b1d3225743ba294b1c105549940ea6b801bcd6d68aea4a3b97df5ac8f- Stable URL of this page
https://metraipolis.com/documento/dc_6df6a07f3ccd
How to cite
R263K-associated dolutegravir resistance on tenofovir, lamivudine and dolutegravir: Implications for earlier genotyping and regimen optimisation — Europe PMC PMID:41959931 — Europe PMC (en), https://europepmc.org/article/MED/41959931 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6df6a07f3ccd (Metraipolis archive dc_6df6a07f3ccd, sha256 9106940b1d3225743ba294b1c105549940ea6b801bcd6d68aea4a3b97df5ac8f)
BibTeX
@misc{dc6df6a07f3ccd,
title = {R263K-associated dolutegravir resistance on tenofovir, lamivudine and dolutegravir: Implications for earlier genotyping and regimen optimisation — Europe PMC PMID:41959931},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41959931},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6df6a07f3ccd; sha256 9106940b1d3225743ba294b1c105549940ea6b801bcd6d68aea4a3b97df5ac8f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41959931. Agents can read the archived copy with the MCP tool read_document.